title: TGF-β2: A Novel Target of CD44-Promoted Breast Cancer Invasion.
abstract: We have developed a tetracycline (tet)-off regulated expression of CD44s gene in the breast cancer (BC) cell line MCF-7 (B5 clone) and identified TGF-β2 (Transforming Growth Factor beta-2; 3 fold induction) as a potential CD44-downstream transcriptional target by microarray analysis. To further validate this finding, the same RNA samples, used for microarray analysis and their corresponding protein lysates, collected from the BC cell line MCF-7-B5, were examined for CD44 expression in the presence of HA. Our results showed that TGF-β2 mRNA levels were significantly elevated following the removal of tetracycline at 18, 24, and 48 h post-HA stimulation compared to the parental cells. Furthermore, the TGF-β2 precursor protein increased in a time-dependent pattern upon HA-stimulation and in the absence of tetracycline. More interestingly, inhibition of CD44 gene by RNAi method decreased TGF-β2 expression upon HA-stimulation, and subsequently inhibited BC cell invasion in vitro. In addition to identifying TGF-β2 as a target for HA/CD44 signaling, this data suggests that ATF/CREB might be a potential transcription factor linking HA/CD44 activation to TGF-β2 transcription and additional experiments are required for a better understanding of the molecular mechanisms underpinning the novel function of the CD44/ TGF-β2 signaling pathway in breast cancer metastasis.
authors: 1. Department of Genetics.
authors: Allal
authors: A
authors: Ouhtit
authors: Samineh
authors: S
authors: Madani
authors: Ishita
authors: I
authors: Gupta
authors: Somya
authors: S
authors: Shanmuganathan
authors: Mohamed E
authors: ME
authors: Abdraboh
authors: Hamad
authors: H
authors: Al-Riyami
authors: Yahya M
authors: YM
authors: Al-Farsi
authors: Madhwa Hg
authors: MH
authors: Raj
keywords: Breast cancer; CD44; CRE/ATF; Hyaluronan; MCF-7-B5 clone; Metastasis; TGF-β2; Tetracycline-inducible
references: J Biol Chem. 1999 Nov 26;274(48):34020-8
references: 10567368
references: EMBO J. 2002 Aug 1;21(15):3949-59
references: 12145196
references: Front Biosci. 2007 Jan 01;12:1260-70
references: 17127378
references: J Cell Biol. 2001 Nov 26;155(5):755-62
references: 11714729
references: Eur J Surg Oncol. 2003 Jun;29(5):475-9
references: 12798754
references: Cancer Res. 2012 Sep 1;72(17):4597-608
references: 22787120
references: J Biol Chem. 2002 Oct 18;277(42):39703-12
references: 12145287
references: Breast Cancer Res. 2005;7(1):21-32
references: 15642178
references: J Cell Biol. 2002 Jan 21;156(2):299-313
references: 11790801
references: Oncogene. 2006 Oct 5;25(45):6079-91
references: 16652145
references: Front Biosci. 1998 Jul 01;3:d616-30
references: 9634544
references: Proteins. 2000 May 1;39(2):103-11
references: 10737932
references: J Mol Histol. 2004 Mar;35(3):211-31
references: 15339042
references: Am J Pathol. 2011 Aug;179(2):555-63
references: 21718681
references: Cancer Res. 2009 Feb 1;69(3):828-35
references: 19141644
references: Recent Results Cancer Res. 2008;177:137-50
references: 18084956
references: Am J Pathol. 2007 Dec;171(6):2033-9
references: 17991717
references: Cancer Res. 2012 Mar 15;72(6):1449-58
references: 22271686
references: Nat Rev Cancer. 2004 Jul;4(7):528-39
references: 15229478
references: Mol Cancer Res. 2008 May;6(5):695-705
references: 18505915
references: Ann N Y Acad Sci. 2006 Nov;1089:119-26
references: 17261761
references: J Biol Chem. 2004 Jun 11;279(24):25326-32
references: 15084590
references: Cell. 1991 Jan 25;64(2):327-36
references: 1703045
references: Int J Exp Pathol. 2012 Apr;93(2):148-56
references: 22414291
references: J Biol Chem. 2004 Feb 6;279(6):4541-50
references: 14623895
references: J Cell Biochem. 2005 Oct 15;96(3):447-62
references: 16088940
references: Histopathology. 2003 Jun;42(6):546-54
references: 12786890
references: Curr Biol. 1998 Nov 19;8(23):1243-52
references: 9822576
references: Oncogene. 2003 Mar 13;22(10):1511-6
references: 12629514
references: Clin Cancer Res. 2004 Jan 15;10(2):491-8
references: 14760070
references: J Biol Chem. 2010 Feb 5;285(6):4060-4073
references: 19965872
references: Adv Cancer Res. 1997;71:241-319
references: 9111868
references: Cancer Res. 2005 Aug 1;65(15):6755-63
references: 16061657
references: Curr Pharm Biotechnol. 2011 Dec;12(12):2158-64
references: 21619533